On 19 December 2016, the European Medicines Agency (“EMA”) published an updated version of the EMA guidance document concerning post-authorisation procedural advice for users of ...24 January 2017
U.S. tax reform: elements of reform already being developed by Congress
The make-up of this tax reform package – to be debated in Congress starting this year and into 2013 – will depend significantly upon the outcome of the November 2012 U.S. elections. There is little doubt, however, given growing bipartisan interest and fiscal pressure, that there will be a significant tax reform package moving in the next Congress.
Our tax policy analysts, including several veterans of the 1986 Tax Reform Act, are already watching and engaged closely in developments in this area. Areas of the tax code most likely to be targeted for change are identified in a recent client alert.
Regulation (EU) No 536/2014 of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (“the Clinical Trials Regulation”) was...24 January 2017
The UK Medicines and Healthcare products Regulatory Agency (“MHRA”) has published a draft strategy for developing pharmacopoeial public quality standards for biological...20 January 2017